2024-07-1969799.25 KB91页27
TYPEOriginalResearchPUBLISHEDAugustDOI./fnins..OPENACCESSLocalandglobalconvolutionaltransformer-basedmotorEDITEDBYimageryEEGclassificationShugengChen,JiayangZhang,KangLi,BanghuaYangandXiaofeiHanFudanUniversity,ChinaSchoolofElectricalEngineering,UniversityofLeeds,Leeds,UnitedKingdom,SchoolofMechatronicREVIEWEDBYEngineeringandAutomation,ShanghaiUniversity,Shanghai,ChinaGiuliaCisotto,Transformer,a... 2024-07-21691.91 MB12页14
2024-07-26691.09 MB17页
2024-07-26696.28 MB53页
2024-07-3169134 KB9页
2024-07-3169686.05 KB31页
2024-07-31694.46 MB61页
2024-07-316943.11 KB14页
2024-07-31696.54 MB44页
2024-07-3169679.18 KB39页
2024-07-316921.96 MB130页
2024-08-126969.05 KB3页
2024-08-12692.7 MB42页
2024-08-12691.89 MB49页
2025-04-146915.38 MB126页1
2025-04-1669264.27 MB1616页1
The 52nd edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug information, spiral-bound and printed in a larger font (approximately 8pt) for ease of use. Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, The Sanford Guide provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians. Coverage includes: Clinical syndromes (pathogens, bacterial, fungal, mycobacterial, parasitic viral), Anti-infective agents (dosing, pediatric adjustments, renal adjustments, adverse effects, activity, pharmacology, drug-drug interactions), Preventative therapy. What's new in 2022: Numerous changes throughout, with major changes in the following areas: New Drugs - Addition of new COVID-19 drugs, cefiderocol, ibrexafungerp, brincidofovir, cabotegravir, doravirine, and more. New Tables - ECMO Drug Dos 2025-04-176932.87 MB324页
2025-05-136921.39 MB96页1
2024-07-19682.69 MB40页11
2024-07-1968126 KB30页21
